Ohnuma Hiroyuki 大沼啓之

… Alternative Names

OHNUMA Hiroyuki 大沼啓之

Less

Researcher Number	60582997
Other IDs	https://orcid.org/0000-0002-4350-6971
Affiliation (Current)	2025: 札幌医科大学, 医学部, 講師
Affiliation (based on the past Project Information) *help	2020 – 2023: 札幌医科大学, 医学部, 講師 2013 – 2014: 札幌医科大学, 医学部, 助教
Review Section/Research Field	Principal Investigator Basic Section 53010:Gastroenterology-related / Gastroenterology
Keywords	Principal Investigator 効果予測因子 / miRNA / 感受性予測 / 化学放射線療法 / 食道癌 / 耐性機構 / 薬剤感受性 / 放射線感受性

Analyzing and overcoming chemoradiation resistance mechanism for esophageal squamous cell carcinoma through miRNA functional analysisPrincipal Investigator
- Principal Investigator
  
  大沼啓之
- Project Period (FY)
  2023 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53010:Gastroenterology-related
- Research Institution
  Sapporo Medical University
Establishment of a system by miRNA analysis to predict prognoses of cases with esophageal squamous cell carcinoma treated by chemoradiotherapy.Principal Investigator
- Principal Investigator
  
  Ohnuma Hiroyuki
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53010:Gastroenterology-related
- Research Institution
  Sapporo Medical University
Development of the method for predicting sensitivity to chemoradiothrapy for esophageal cancer using comprehensive gene expression profiling analysisPrincipal Investigator
- Principal Investigator
  
  OHNUMA Hiroyuki
- Project Period (FY)
  2013 – 2014
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Gastroenterology
- Research Institution
  Sapporo Medical University

All 2023 2021 2015 Other

All Presentation

[Presentation] Definitive chemoradiation therapy with docetaxel, nedaplatin, and 5-fluorouracil (DNF-R) for locally advanced esophageal cancer. - long-term follow-up -2023
- Author(s)
  大沼啓之
- Organizer
  第20回日本臨床腫瘍学会学術集会
- Data Source
  KAKENHI-PROJECT-23K07378
[Presentation] 切除可能進行食道癌に対する三剤併用療法ベースの化学放射線療法は手術療法を代替できるか?:傾向スコアマッチング分析2021
- Author(s)
  大沼啓之
- Organizer
  第128回日本消化器病学会北海道支部例会
- Data Source
  KAKENHI-PROJECT-20K08360
[Presentation] 切除可能進行食道癌に対する三剤併用療法ベースの化学放射線療法は手術療法を代替できるか?:傾向スコアマッチング分析2021
- Author(s)
  大沼啓之
- Organizer
  第128回日本消化器病学会北海道支部例会
- Data Source
  KAKENHI-PROJECT-20K08360
[Presentation] 進行食道癌に対するdocetaxel，nedaplatin, 5-FU，放射線同時併用療法（DNF-R）の第Ⅰ/Ⅱ相試験2015
- Author(s)
  大沼啓之，佐藤康史，大須賀崇裕，佐川保，林毅，佐藤勉，宮西浩嗣，小船雅義，瀧本理修，堀正和，染谷正則，中田健生，坂田耕一，加藤淳二
- Organizer
  第42回北海道食道癌研究会
- Place of Presentation
  札幌市教育文化会館 (北海道，札幌市)
- Year and Date
  2015-04-11
- Data Source
  KAKENHI-PROJECT-25860546
[Presentation] A phase I/II study of definitive chemoradiotherapy with docetaxel, nedaplatin, and 5-fluorouracil (DNF-R) for advanced esophageal cancer.
- Author(s)
  Yasushi Sato, Hiroyuki Ohnuma, Masahiro Hirakawa, Yutaka Okagawa, Takahiro Osuga, Kazuyuki Murase, Kohichi Takada, Yutaka Kawano, Satoshi Iyama, Tsuyoshi Hayashi, Tsutomu Sato, Koji Miyanishi, Rishu Takimoto, Masayoshi Kobune, Tamotsu Sagawa, Masakazu Hori, Masanori Someya, Koh-ichi Sakata, Tetsuji Takayama, Junji Kato
- Organizer
  2015 Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology
- Place of Presentation
  Moscone West Building (San Francisco, CA)
- Year and Date
  2015-01-15 – 2015-01-17
- Data Source
  KAKENHI-PROJECT-25860546

1. 久保智洋 (00634669)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
2. 加藤淳二 (20244345)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
3. 高田弘一 (90398321)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results

Ohnuma Hiroyuki 大沼 啓之

OHNUMA Hiroyuki 大沼 啓之

Research Projects

Research Products

Co-Researchers

Analyzing and overcoming chemoradiation resistance mechanism for esophageal squamous cell carcinoma through miRNA functional analysisPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Establishment of a system by miRNA analysis to predict prognoses of cases with esophageal squamous cell carcinoma treated by chemoradiotherapy.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of the method for predicting sensitivity to chemoradiothrapy for esophageal cancer using comprehensive gene expression profiling analysisPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Presentation] Definitive chemoradiation therapy with docetaxel, nedaplatin, and 5-fluorouracil (DNF-R) for locally advanced esophageal cancer. - long-term follow-up -2023

Author(s)

Organizer

Data Source

[Presentation] 切除可能進行食道癌に対する三剤併用療法ベースの化学放射線療法は手術療法を代替できるか?:傾向スコアマッチング分析2021

Author(s)

Organizer

Data Source

[Presentation] 切除可能進行食道癌に対する三剤併用療法ベースの化学放射線療法は手術療法を代替できるか?:傾向スコ アマッチング分析2021

Author(s)

Organizer

Data Source

[Presentation] 進行食道癌に対するdocetaxel，nedaplatin, 5-FU，放射線同時併用療法（DNF-R）の第Ⅰ/Ⅱ相試験2015

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] A phase I/II study of definitive chemoradiotherapy with docetaxel, nedaplatin, and 5-fluorouracil (DNF-R) for advanced esophageal cancer.

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

Ohnuma Hiroyuki 大沼啓之

OHNUMA Hiroyuki 大沼啓之

[Presentation] 切除可能進行食道癌に対する三剤併用療法ベースの化学放射線療法は手術療法を代替できるか?:傾向スコアマッチング分析2021